Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics.
about
Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.Treatment of hepatitis C virus genotype 1-infected patients: mission accomplished?Advances in nanomedicine drug delivery applications for HIV therapy.Novel elvitegravir nanoformulation approach to suppress the viral load in HIV-infected macrophages.Recent advances of controlled drug delivery using microfluidic platforms.Considerations for clinically-relevant nanomedicine therapies for chronic diseases
P2860
Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Nanoformulation strategies for ...... f antiretroviral therapeutics.
@en
type
label
Nanoformulation strategies for ...... f antiretroviral therapeutics.
@en
prefLabel
Nanoformulation strategies for ...... f antiretroviral therapeutics.
@en
P2860
P356
P1433
P1476
Nanoformulation strategies for ...... f antiretroviral therapeutics.
@en
P2093
Lee M Tatham
P2860
P304
P356
10.4155/TDE.15.4
P577
2015-04-01T00:00:00Z